Bavarian Nordic A/S (BV3)
XETR
Real-time Data
07:00 AM
Day's Range
28.9252 wk Range
22.96Overview - BV3 - Bavarian Nordic A/S
Key Statistics
Valuation
Enterprise Value
-5.11M
P/E (Trailing)
‪11.16‬
PEG Ratio
‪-0.12‬
Price / Sales (TTM)
‪0.34‬
Price / Book
‪1.24‬
EV / EBITDA
‪-0.02‬
Profitability
Gross Margin
‪44.82%‬
Profit Margin
‪24.33%‬
Operating Margin
‪36.80%‬
Return on Assets
‪5.00%‬
Return on Equity
‪12.21%‬
Ownership
Shares Outstanding
77.14M
Float
75.54M
Held by Insiders
‪0.01%‬
Held by Institutions
‪34.11%‬
Price stats
Beta
‪0.94‬
50-Day Avg
‪24.67‬
200-Day Avg
‪25.33‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - BV3 - Bavarian Nordic A/S
Peers - BV3 - Bavarian Nordic A/S
Peer Comparison
Compared with companies in Biotechnology listed on XETR.
Profile Summary - BV3 - Bavarian Nordic A/S
About
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing, and commercialization of vaccines. The company specializes in life-saving immunizations for infectious diseases, with a commercial portfolio that includes vaccines for smallpox, mpox, rabies, tick-borne encephalitis,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
